PRINOXODAN (RG W-2938)

[1] ABEL FL, 1988, CIRC SHOCK, V24, P84

[2] APPLEBY S, 1989, FASEB J, V3, P4732

[3] PHARMACOLOGY OF RG W-2938 - A CARDIOTONIC AGENT WITH VASODILATOR ACTIVITY [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 16 (04) : 537 - 545

[4] BARRETT JA, 1988, FED PROC, V2, P301

[5] BARRETT JA, 1987, PHARMACOLOGIST, V29, P135

[6] BERGER P, 1989, PHAARDIOVASC PHARM, V31, P153

[7] BONIFACE KJ, 1953, P SOC EXP BIOL MED, V84, P263

[8] BRAUNWALD E, 1979, HDB PHYSL 2, V1, P545

[9] EVANS DB, 1982, PHARMACOL THERAPEUT, V6, P303

[10] DEFICIENT PRODUCTION OF CYCLIC-AMP - PHARMACOLOGICAL EVIDENCE OF AN IMPORTANT CAUSE OF CONTRACTILE DYSFUNCTION IN PATIENTS WITH END-STAGE HEART-FAILURE [J]. CIRCULATION, 1987, 75 (02) : 331 - 339

[1] ABEL FL, 1988, CIRC SHOCK, V24, P84

[2] APPLEBY S, 1989, FASEB J, V3, P4732

[3] PHARMACOLOGY OF RG W-2938 - A CARDIOTONIC AGENT WITH VASODILATOR ACTIVITY [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 16 (04) : 537 - 545

[4] BARRETT JA, 1988, FED PROC, V2, P301

[5] BARRETT JA, 1987, PHARMACOLOGIST, V29, P135

[6] BERGER P, 1989, PHAARDIOVASC PHARM, V31, P153

[7] BONIFACE KJ, 1953, P SOC EXP BIOL MED, V84, P263

[8] BRAUNWALD E, 1979, HDB PHYSL 2, V1, P545

[9] EVANS DB, 1982, PHARMACOL THERAPEUT, V6, P303

[10] DEFICIENT PRODUCTION OF CYCLIC-AMP - PHARMACOLOGICAL EVIDENCE OF AN IMPORTANT CAUSE OF CONTRACTILE DYSFUNCTION IN PATIENTS WITH END-STAGE HEART-FAILURE [J]. CIRCULATION, 1987, 75 (02) : 331 - 339